project id: TCGA-UCEC; case submitter id: TCGA-B5-A5OC; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 8.5; age at index: 71; days to birth: -26109; ethnicity: not reported; gender: female; race: black or african american; vital status: Alive; year of birth: 1940; age at diagnosis: 26109; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1249.0; figo stage: Stage IIIB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 732; days to sample procurement: 0; initial weight: 750.0; portion submitter id: TCGA-B5-A5OC-01A-21; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 40.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;